CPS Algorithm Development

About Sensydia

Sensydia is a private medical device company developing a novel, non-invasive diagnostic platform called the Cardiac Performance System (CPS). The CPS uses proprietary sensors and machine learning algorithms to measure critical hemodynamic parameters like ejection fraction, cardiac output, and pulmonary artery pressure without invasive catheters. Its technology aims to transform point-of-care cardiac assessment in hospitals and clinics by providing rapid, accurate data to guide treatment for heart failure and critical care patients, potentially reducing costs and readmissions. The company has an FDA clearance for Ejection Fraction measurement and is advancing its pipeline for additional indications.

Therapeutic Areas